Connecticut 2013 Regular Session

Connecticut House Bill HB05347

Introduced
1/17/13  
Introduced
1/17/13  
Refer
1/17/13  
Refer
1/17/13  
Refer
3/5/13  
Refer
3/5/13  
Report Pass
3/12/13  
Report Pass
3/12/13  
Refer
3/19/13  
Refer
3/19/13  
Report Pass
3/26/13  

Caption

An Act Concerning Prescription Drug Labels.

Impact

The act is expected to significantly impact the way prescription drugs are labeled, creating a standard across the state that could enhance consumer safety. By including expiration dates that can be easily read and understood, the bill addresses concerns related to medication waste and the potential health risks associated with expired drugs. Additionally, the requirement to list both the generic and brand name for non-brand drugs is aimed at increasing awareness and understanding among consumers, potentially improving health outcomes and medication adherence.

Summary

House Bill 5347 aims to enhance the clarity and safety of prescription drug labels by imposing specific requirements on pharmacists. Effective January 1, 2014, the bill mandates that pharmacists must include the quantity of the prescribed drug and a prominently displayed expiration date on prescription containers. This initiative is intended to ensure that patients have access to important information regarding their medications, particularly concerning their safety and effective use based on the manufacturer's recommendations.

Sentiment

Overall, the sentiment around HB 5347 appears to be positive, with a broad consensus on the importance of clear drug labeling for public health. Supporters are likely to include healthcare professionals advocating for patient safety and clear communication about medications. However, there might be concerns raised by some pharmacy stakeholders regarding the administrative burden placed on pharmacists in terms of compliance with these new labeling requirements.

Contention

While the bill is largely well-received, there may be some points of contention surrounding the practical implications of implementing these new requirements. Some may argue that adding additional information to labels could lead to clutter or confusion, particularly for individuals who may have difficulty reading smaller print. Furthermore, discussions could arise regarding the costs associated with updating labeling practices at pharmacies, especially for smaller establishments that may face financial constraints.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.